Evidence map›Paper›PMID 25933350›Full record

ArticlemAbs2015

Characterizing monoclonal antibody structure by carboxyl group footprinting.

Parminder Kaur, Sara E Tomechko, Janna Kiselar, Wuxian Shi, Galahad Deperalta, Aaron T Wecksler, Giridharan Gokulrangan, Victor Ling, Mark R Chance

Open access · goldAbstract read
In one paragraph

Article in mAbs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Parminder Kaura Center for Proteomics and Bioinformatics; School of Medicine; Case Western Reserve University ; Cleveland , OH , USA.
Sara E Tomechko
Janna Kiselar
Wuxian Shi
Galahad Deperalta
Aaron T Wecksler
Giridharan Gokulrangan
Victor Ling
Mark R Chance
Case Western Reserve University · USKaiser Permanente South San Francisco Medical Center · USIndiana University School of MedicinePulmonary and Critical Care Associates · US

Funding

NIBIB NIH HHS P30-EB-09866NIBIB NIH HHS R01-EB-09998
6 · The paper itself

Abstract

Structural characterization of proteins and their antigen complexes is essential to the development of new biologic-based medicines. Amino acid-specific covalent labeling (CL) is well suited to probe such structures, especially for cases that are difficult to examine by alternative means due to size, complexity, or instability. We present here a detailed account of carboxyl group labeling (with glycine ethyl ester (GEE) tagging) applied to a glycosylated monoclonal antibody therapeutic (mAb). The experiments were optimized to preserve the structural integrity of the mAb, and experimental conditions were varied and replicated to establish the reproducibility of the technique. Homology-based models were generated and used to compare the solvent accessibility of the labeled residues, which include aspartic acid (D), glutamic acid (E), and the C-terminus (i.e., the target probes), with the experimental data in order to understand the accuracy of the approach. Data from the mAb were compared to reactivity measures of several model peptides to explain observed variations in reactivity. Attenuation of reactivity in otherwise solvent accessible probes is documented as arising from the effects of positive charge or bond formation between adjacent amine and carboxyl groups, the latter accompanied by observed water loss. A comparison of results with previously published data by Deperalta et al using hydroxyl radical footprinting showed that 55% (32/58) of target residues were GEE labeled in this study whereas the previous study reported 21% of the targets were labeled. Although the number of target residues in GEE labeling is fewer, the two approaches provide complementary information. The results highlight advantages of this approach, such as the ease of use at the bench top, the linearity of the dose response plots at high levels of labeling, reproducibility of replicate experiments (<2% variation in modification extent), the similar reactivity of the three target probes, and significant correlation of reactivity and solvent accessible surface area.

Indexed as

AnimalsAntibodies, Monoclonal, Murine-DerivedGlycosylationMicePeptidesAntibodies, Monoclonal, Murine-DerivedPeptides1-ethyl-3-(3-dimethylaminopropyl)carbodiimideacetonitrileACN, acetonitrileCD, circular dichroismcircular dichroismCL, covalent labelingcovalent labelingdose responseDR, dose responseEDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimideEIC, extracted ion chromatogramextracted ion chromatogramGEE, glycine ethyl esterglycine ethyl esterHC, heavy chainHDX, hydrogen-deuterium exchangeheavy chainHRF, hydroxyl radical footprintinghydrogen-deuterium exchangehydroxyl radical footprintingIgG, immunoglobulin gammaimmunoglobulin gammaion trapIT, ion trapLC, light chainlight chainLys-C, lysyl endopeptidaselysyl endopeptidasemAb, monoclonal antibodymass spectrometrymonoclonal antibodyMS, mass spectrometryrate constantRC, rate constantSASA, solvent accessible surface areaSEC, size-exclusion chromatographysize-exclusion chromatographysolvent accessible surface area

Identifiers

PMID25933350
PMCPMC4622658
OpenAlexW2221654582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.